| ŽÁČKOVÁ, Daniela, Hana KLAMOVÁ, Jan MUŽÍK, Edmund CMUNT, Zdeněk RÁČIL, Kateřina MACHOVÁ POLÁKOVÁ, Dana DVOŘÁKOVÁ, Tomáš JURČEK, Filip RÁZGA, Petr CETKOVSKÝ, Ladislav DUŠEK a Jiří MAYER. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. Leukemia & Lymphoma. London: Informa Healthcare, Gordon and Breach, 2013, roč. 54, č. 10, s. 2310-2313. ISSN 1042-8194. doi:10.3109/10428194.2013.772173. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1139161,
author = {Žáčková, Daniela and Klamová, Hana and Mužík, Jan and Cmunt, Edmund and Ráčil, Zdeněk and Machová Poláková, Kateřina and Dvořáková, Dana and Jurček, Tomáš and Rázga, Filip and Cetkovský, Petr and Dušek, Ladislav and Mayer, Jiří},
article_location = {London},
article_number = {10},
doi = {http://dx.doi.org/10.3109/10428194.2013.772173},
keywords = {chronic myeloid leukemia; formal clinical trials; dasatinib; imatinib},
language = {eng},
issn = {1042-8194},
journal = {Leukemia & Lymphoma},
title = {Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.},
url = {http://informahealthcare.com/doi/abs/10.3109/10428194.2013.772173},
volume = {54},
year = {2013}
}
TY - JOUR
ID - 1139161
AU - Žáčková, Daniela - Klamová, Hana - Mužík, Jan - Cmunt, Edmund - Ráčil, Zdeněk - Machová Poláková, Kateřina - Dvořáková, Dana - Jurček, Tomáš - Rázga, Filip - Cetkovský, Petr - Dušek, Ladislav - Mayer, Jiří
PY - 2013
TI - Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.
JF - Leukemia & Lymphoma
VL - 54
IS - 10
SP - 2310-2313
EP - 2310-2313
PB - Informa Healthcare, Gordon and Breach
SN - 10428194
KW - chronic myeloid leukemia
KW - formal clinical trials
KW - dasatinib
KW - imatinib
UR - http://informahealthcare.com/doi/abs/10.3109/10428194.2013.772173
L2 - http://informahealthcare.com/doi/abs/10.3109/10428194.2013.772173
N2 - Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials.
ER -
ŽÁČKOVÁ, Daniela, Hana KLAMOVÁ, Jan MUŽÍK, Edmund CMUNT, Zdeněk RÁČIL, Kateřina MACHOVÁ POLÁKOVÁ, Dana DVOŘÁKOVÁ, Tomáš JURČEK, Filip RÁZGA, Petr CETKOVSKÝ, Ladislav DUŠEK a Jiří MAYER. Efficacy and tolerance of dasatinib after imatinib failure or intolerance for patients with chronic myeloid leukemia treated in three different hospitals compare well with results achievable in formal clinical trials. \textit{Leukemia \&{} Lymphoma}. London: Informa Healthcare, Gordon and Breach, 2013, roč.~54, č.~10, s.~2310-2313. ISSN~1042-8194. doi:10.3109/10428194.2013.772173.
|
